- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00924846
High-Frequency Oscillatory Ventilation Associated With Inhaled Nitric Oxide in Children
High-Frequency Oscillatory Ventilation Associated With Inhaled Nitric Oxide in Children: Randomized, Crossover Study
Background/Objectives: Acute hypoxemic respiratory failure (AHRF) is a frequent cause of pediatric ICU admission. Early treatment with inhaled nitric oxide (iNO) plus conventional mechanical ventilation (CMV) improves oxygenation, responsiveness being significantly influenced by alveolar recruitment level. High-frequency oscillatory ventilation (HFV) is conceptually very attractive as constant mean airway pressure optimizes lung recruitment; this could maximize iNO effects.
Aims: To analyze the effects of HFV on oxygenation indexes in AHRF children under CMV and iNO.
Methods: Children with AHRF (oxygenation index ≥10) aged between one month and 14 years under CMV with PEEP≥10cmH2O and 5ppm iNO for 1h were randomly assigned to CMV (CMVG, n=12) or HFV (HFVG, n=12) in a crossover design. Children with chronic cardiac or pulmonary diseases were excluded. Patients were kept under one of the two ventilation modes for 8h, crossing to the other for 8h, and then back again to complete 24h observation. Blood gas analysis, oxygenation indexes, and hemodynamic variables were recorded at enrollment (Tind), 1h after iNO start and then every 4h (T4h etc). The Mann-Whitney U test compared group ages and PRISM scores, and the Fisher test genders. Moments and groups were compared by repeated measure analysis for independent groups. Significance was considered at p<0.05.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Acute hypoxemic respiratory failure (AHRF) is a frequent cause of admission and complicates evolution of critically ill children. Mortality rate is still high, mainly when acute respiratory distress syndrome (ARDS) evolves.
Clinical management of AHRF is essentially supportive and includes control of underlying infections, fluid balance and hemodynamic status, nutritional support, and optimized protective mechanical ventilation4,5,6. Ventilatory strategies should be directed at minimizing ventilator-induced lung injury (VILI), eliminating oxygen toxicity, and controlling lung inflammation. Also, when hypoxemia persists, additional treatments may be implemented, such as inhaled nitric oxide (iNO)and high-frequency oscillatory ventilation (HFOV).
Recently, we have demonstrated that early treatment with iNO associated with protective conventional mechanical ventilation (CMV) causes acute and sustained improvement in oxygenation, with earlier reduction in ventilator settings that are associated with a high risk of VILI and oxygen toxicity; this might contribute to reducing the mortality rate in children with ARDS.
However, many studies have given no value to iNO therapy because of a lack of impact on mortality rate. Despite this, it should be considered that the improvement in oxygenation promoted by NO inhalation may be useful as rescue therapy. Also, it is known that responsiveness to iNO can be significantly influenced by applying sufficient positive and expiratory pressure (PEEP), as this seems to recruit additional alveoli for gas exchange. In this sense, HFOV is very attractive as the application of a constant mean airway pressure maintains an "open lung" and optimizes lung recruitment; this could maximize iNO effects.
Two experimental studies have shown increased iNO effects when the gas was used together with HFOV. In ARDS adults, Authors studied this association and demonstrated improvement in oxygenation with significant reduction in FiO2, probably due to the degree of alveolar recruitment during HFOV which may increase the amount of alveolar/capillary interface available for iNO to act upon.
In pediatrics, there is one study combining iNO and HFOV in newborn babies with severe persistent pulmonary hypertension which concluded that the association is often more successful than each treatment alone23. After neonatal period, a retrospective (post hoc) data analysis from a multicenter, randomized controlled trial on the effects of iNO in the treatment of AHRF concluded that the combination of HFOV with iNO causes greater improvement in oxygenation than either treatment strategy alone.
Therefore, the question about the potential role of the association between iNO therapy and HFOV in AHRF children is still open and remains to be defined. Our hypothesis is the association between early iNO treatment and HFOV improves oxygenation more consistently and for longer time than the association of the gas with protective conventional mechanical ventilation.
The aim of this study was to analyze the effects of HFOV on oxygenation indexes in AHRF children under CMV and iNO therapy.
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Sao Paulo
-
Botucatu, Sao Paulo, Brazil, 18.618-970
- UNESP-Botucatu Medical School
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Children with AHRF (oxygenation index ≥ 10) aged between one month and 14 years under CMV with PEEP ≥ 10 cmH2O and 5 ppm iNO for 1 hour.
Exclusion Criteria:
- Children with chronic cardiac or pulmonary diseases.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: HFOV plus iNO
HFOV plus iNO: high frequency oscillatory ventilation plus inhaled nitric oxide
|
Mechanical ventilation as high frequency oscillatory ventilation for 8h periods
Other Names:
|
Active Comparator: CMV plus iNO
CMV (conventional mechanical ventilation) iNO (inhaled nitric oxide)
|
Mechanical ventilation as high frequency oscillatory ventilation for 8h periods
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Oxygenation indexes
Time Frame: 2 years
|
2 years
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Jose R Fioretto, MD, PhD, UNESP-Botucatu Medical School
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- upeclin/HC/FMB-Unesp-26
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Hypoxemic Respiratory Failure
-
Beijing Chao Yang HospitalRecruitingPatients With Acute Hypoxemic Respiratory FailureChina
-
Dr. Behcet Uz Children's HospitalCompletedAcute Respiratory Failure | Acute Hypoxemic Respiratory Failure | Acute Hypoxemic and Hypercapnic Respiratory FailureTurkey
-
Yonsei UniversityNot yet recruitingRespiratory Failure | Respiratory Insufficiency | Hypercapnic Respiratory Failure | Acute Hypoxemic Respiratory Failure | Acute Hypercapnic Respiratory Failure | Ventilatory Depression | Hypoxemic Respiratory Failure | Respiratory Depression | Hypoxemic Acute Respiratory Failure | Hypercapnic AcuteKorea, Republic of
-
Hospital General Universitario Morales MeseguerNot yet recruitingEvaluation of Prone Position Effect During NIV and HFNC on Acute Hypoxemic Respiratory Failure
-
Niguarda HospitalRecruitingPneumonia-associated Acute Hypoxemic Respiratory FailureItaly
-
Poitiers University HospitalRecruitingAcute Respiratory Failure | Hypoxemic Respiratory FailureFrance
-
Nantes University HospitalCompletedHypoxemic Acute Respiratory FailureFrance
-
Sunnybrook Health Sciences CentreRecruitingAcute Hypoxemic Respiratory FailureCanada
-
Siriraj HospitalRecruitingAcute Hypoxemic Respiratory Failure | Acute Hypercapnic Respiratory FailureThailand
-
Fisher and Paykel HealthcareCentre hospitalier de l'Université de Montréal (CHUM); Institut universitaire...Not yet recruitingAcute Hypoxemic Respiratory Failure | Acute Hypercapnic Respiratory Failure
Clinical Trials on High frequency oscillatory ventilation
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedRespiratory Distress Syndrome, AdultUnited States
-
Ain Shams UniversityNot yet recruitingEffect of Volume Guarantee-High Frequency Oscillatory Ventilation on Cerebral Blood Flow in NeonatesRespiratory Tract Diseases | Cerebral Blood Flow | Infant, Premature, DiseasesEgypt
-
Guangzhou Institute of Respiratory DiseaseNot yet recruitingCOPD | Non-invasive VentilationChina
-
Canadian Critical Care Trials GroupCanadian Institutes of Health Research (CIHR); McMaster University; University...TerminatedAcute Respiratory Distress Syndrome (ARDS)Chile, Canada, United States, India, Saudi Arabia
-
Guangzhou Institute of Respiratory DiseaseNot yet recruitingHealthy Subjects | Non-invasive VentilationChina
-
Guangzhou Institute of Respiratory DiseaseNot yet recruitingCOPD Exacerbation | Non-invasive Ventilation
-
The Hospital for Sick ChildrenCompleted
-
Indus Hospital and Health NetworkWithdrawnRespiratory Distress Syndrome in Premature InfantPakistan
-
Ain Shams UniversityRecruitingRespiratory Tract Diseases | Infant, Premature, Diseases | Infant, Newborn, Disease | RDSEgypt
-
University of UtahRecruitingCongenital Diaphragmatic HerniaUnited States